Jeffrey D Altenburg

Summary

Affiliation: Clarian Health Partners
Country: USA

Publications

  1. doi Docosahexaenoic acid downregulates interferon gamma-induced expression of CXCL16 in human aortic smooth muscle cells
    Jeffrey D Altenburg
    Cellular Biochemistry Laboratory, Methodist Research Institute, Clarian Health Partners, Indianapolis, IN 46202, United States
    Biochem Biophys Res Commun 391:609-14. 2010
  2. doi Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects
    Rafat A Siddiqui
    Cellular Biochemistry Laboratory, Indiana University Health, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Biofactors 37:399-412. 2011
  3. doi A novel 2,6-diisopropylphenyl-docosahexaenoamide conjugate induces apoptosis in T cell acute lymphoblastic leukemia cell lines
    Jeffrey D Altenburg
    Cellular Biochemistry Laboratory, Methodist Research Institute, Indiana University Health, Indianapolis, IN 46202, USA
    Biochem Biophys Res Commun 411:427-32. 2011
  4. pmc A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone
    Jeffrey D Altenburg
    Cellular Biochemistry Laboratory, Methodist Research Institute, Indiana University Health, Indianapolis, Indiana, USA
    BMC Cancer 11:149. 2011
  5. pmc Attenuation of niacin-induced prostaglandin D(2) generation by omega-3 fatty acids in THP-1 macrophages and Langerhans dendritic cells
    Justin Vanhorn
    Cellular Biochemistry Laboratory, Methodist Research Institute, Indianapolis
    J Inflamm Res 5:37-50. 2012
  6. doi Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells
    Jeffrey D Altenburg
    Cellular Biochemistry Laboratory, Methodist Research Institute, Clarian Health Partners, Indianapolis, IN 46202, USA
    Mol Cancer Res 7:1013-20. 2009
  7. pmc A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent human immunodeficiency virus type 1 inhibitor with weak chemotaxis and cell survival activities
    Jeffrey D Altenburg
    Department of Microbiology and Immunology, Indiana University School of Medicine, 635 Barnhill Drive, Room 420, Indianapolis, IN 46202, USA
    J Virol 81:8140-8. 2007

Collaborators

Detail Information

Publications7

  1. doi Docosahexaenoic acid downregulates interferon gamma-induced expression of CXCL16 in human aortic smooth muscle cells
    Jeffrey D Altenburg
    Cellular Biochemistry Laboratory, Methodist Research Institute, Clarian Health Partners, Indianapolis, IN 46202, United States
    Biochem Biophys Res Commun 391:609-14. 2010
    ..These findings may prove to be important in other disease fields that identify IFNgamma as a regulator...
  2. doi Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects
    Rafat A Siddiqui
    Cellular Biochemistry Laboratory, Indiana University Health, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Biofactors 37:399-412. 2011
    ..Use of DHA with anticancer treatments provides an avenue to therapeutic improvement that involves less risk or side effects for patients and reduced regulatory burden for implementation...
  3. doi A novel 2,6-diisopropylphenyl-docosahexaenoamide conjugate induces apoptosis in T cell acute lymphoblastic leukemia cell lines
    Jeffrey D Altenburg
    Cellular Biochemistry Laboratory, Methodist Research Institute, Indiana University Health, Indianapolis, IN 46202, USA
    Biochem Biophys Res Commun 411:427-32. 2011
    ..These conjugates have potential use for treatment of patients with T cell acute lymphoblastic leukemia...
  4. pmc A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone
    Jeffrey D Altenburg
    Cellular Biochemistry Laboratory, Methodist Research Institute, Indiana University Health, Indianapolis, Indiana, USA
    BMC Cancer 11:149. 2011
    ....
  5. pmc Attenuation of niacin-induced prostaglandin D(2) generation by omega-3 fatty acids in THP-1 macrophages and Langerhans dendritic cells
    Justin Vanhorn
    Cellular Biochemistry Laboratory, Methodist Research Institute, Indianapolis
    J Inflamm Res 5:37-50. 2012
    ..In conclusion, this study suggests that the regular use of omega-3 PUFAs along with niacin can potentially reduce the niacin-induced flushing response in sensitive patients...
  6. doi Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells
    Jeffrey D Altenburg
    Cellular Biochemistry Laboratory, Methodist Research Institute, Clarian Health Partners, Indianapolis, IN 46202, USA
    Mol Cancer Res 7:1013-20. 2009
    ..This suggests a previously unreported potential benefit of n-3 PUFAs to patients with metastatic breast cancer. The data presented in this study may also translate to other disorders that involve up-regulated chemokine receptors...
  7. pmc A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent human immunodeficiency virus type 1 inhibitor with weak chemotaxis and cell survival activities
    Jeffrey D Altenburg
    Department of Microbiology and Immunology, Indiana University School of Medicine, 635 Barnhill Drive, Room 420, Indianapolis, IN 46202, USA
    J Virol 81:8140-8. 2007
    ....